• Exchange: AktieTorget
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

PharmaLundensis AB

+ Add to Watchlist

PHAL:SS

10.5000 SEK 0.00000.00%

As of 12:00:01 ET on 07/25/2014.

Snapshot for PharmaLundensis AB (PHAL)

Open: 10.5000 Day's Range: 10.3500 - 10.5000 Volume: 3,885
Previous Close: 10.5000 52wk Range: 5.5000 - 13.9000 1-Yr Rtn: -23.91%

Stock Chart for PHAL

No chart data available.
  • PHAL:SS 10.5000
  • 1D
  • 1M
  • 1Y
10.5000
Interactive PHAL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHAL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. OMX -
Earnings Per Share (ttm) -0.3900
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 178.75
Shares Outstanding (M) 17.02
30 Day Average Volume 6,528
Price/Book (mrq) 22.0611
Price/Sale (ttm) 22,344.0000
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHAL

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for PHAL

PharmaLundensis AB is a drug development company. The Company is developing a drug for the treatment of Chronic obstructive pulmonary disease.

Staffan SkogvallCEO/Director:Research
More Company Profile & Key Executives for PHAL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil